Delivery Order SPE2DB24D6039-SPE2DB25FLEHY
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, with a ceiling value of $6,403.84 and a completion date of February 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, with a ceiling value of $2,250.16 and a completion date of May 30, 2025. The contract is not set aside and allows for the delivery of a variety of pharmaceutical and medical products to support military and government healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a ceiling value of $8,714.52 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, under a firm fixed-price contract with a ceiling value of $34,628.80. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of "ABRYSVO VIAL WITH DILUENTS" medical products. The contract has a total ceiling value of $8,657.20 and a completion date of July 17, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,008.35 firm fixed-price contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a period of performance through July 16, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a ceiling value of $2,880.88 and a completion date of June 12, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a firm fixed price ceiling value of $2,401.44 and a period of performance through March 17, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a potential value of $1,583.20 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed price of $8,063.70 and a completion date of October 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLEHYDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ABRYSVO VIAL WITH DILUENT SYRGS. The contract has a ceiling value of $2,018.02 and a completion date of June 26, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order contract is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/25/25 |